Downfall? 6 vital questions on Meta’s future
Montaka CIO, Andrew Macken shares why he believes there is a strong likelihood that Meta will significantly outperform the very low expectations that are currently embedded in Meta’s stock price.
The case for investment optimism: 4 tech advancements that will underpin long-term returns (and the 3 stocks you need to profit from them)
With so much bad news abound, it can be difficult to see any light amidst the economic darkness. But in engineering labs all around the world, extraordinary advancements in technology are being made. In the not-too-distant future, the economic cycle will turn, and the market’s myopia will fade. And when it does, the new market opportunities unlocked by today’s technological advancements will come into focus.
4 reasons why Spotify shares are set for a star revival
Bargain hunters alert! Spotify shares have fallen 75% from their peak in 2021. Should you panic? We don’t think so. Here are 4 key reasons why Spotify can materially increase its earning power in future years and why the stock is way undervalued in our opinion.
How we use the ‘private equity’ approach to invest in (shockingly undervalued) Microsoft
What if we owned all of Microsoft? This article takes a detailed look at how we implement the ‘private equity’ approach to public equities. We also shed light on why we believe that Microsoft is an $US11 trillion opportunity.
Why Amazon should top your ‘bear-market bargain’ list
The current slump suggests the market believes Amazon’s future isn’t too bright but we share 3 key reasons why these prices represent a rare buying opportunity in Amazon.
Bullwhip effect: Why big tech’s woes are temporary (and their shares an extraordinary buying opportunity)
The real reason why investors are wrong to be spooked by big tech earnings. Since their 2021 peaks, the share prices of the world’s largest technology companies have recorded massive declines. Many investors, are thinking about offloading these stocks but the silver lining is that the pain is very likely only temporary.
After COVID-19, mRNA-leader Moderna has the potential to become a major pharma disruptor
The potential for Moderna to exploit mRNA and massively expand its operational scope makes it a compelling investment opportunity that the market is failing to recognize.
Are Alibaba shares oversold?
We do not argue that investing in China isn’t ‘risky’ per-se, but rather, investors are likely to be well-compensated for taking those risks. Looking at Alibaba, the reward to risk ratio is particularly strong making it a compelling investment opportunity.
How Alphabet is using AI to power its future business success
Investors overlook and take for granted that silently sitting beneath the surface of Alphabet is perhaps the most cutting-edge AI apparatus the world has ever seen. Artificial Intelligence is enhancing all areas of Alphabet’s business, from those with valuable monetization models including Search, YouTube and Cloud, to emerging opportunities like autonomous driving (Waymo).
2022 investing game plan: The recent sell-off has put mega caps on sale
– Chris Demasi As Mike Tyson said, ‘everyone has a plan…until they get punched in the face’. That must be how a lot of investors feel just one month into 2022 after sharp falls in equity markets in January. But this recent bout of volatility and market weakness should not be a time to […]
